{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:11:51Z","timestamp":1792692711937,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/nrcardio.2016.183","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T12:41:51Z","timestamp":1480596111000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":606,"title":["Role of gut microbiota in atherosclerosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Annika Lindskog","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"B\u00e4ckhed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"BFnrcardio2016183_CR1","doi-asserted-by":"crossref","unstructured":"Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","DOI":"10.1038\/nature11234"},{"key":"BFnrcardio2016183_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59\u201365 (2010).","journal-title":"Nature"},{"key":"BFnrcardio2016183_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","volume":"32","author":"J Li","year":"2014","unstructured":"Li, J. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834\u2013841 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnrcardio2016183_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer, F. & Backhed, F. The gut microbiota \u2014 masters of host development and physiology. Nat. Rev. Microbiol. 11, 227\u2013238 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"BFnrcardio2016183_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.105.579979","volume":"113","author":"SJ Ott","year":"2006","unstructured":"Ott, S. J. et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113, 929\u2013937 (2006).","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"BFnrcardio2016183_CR6","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren, O. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4592\u20134598 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016183_CR7","doi-asserted-by":"publisher","first-page":"e2010030","DOI":"10.4084\/mjhid.2010.030","volume":"2","author":"M Trevisan","year":"2010","unstructured":"Trevisan, M. & Dorn, J. The relationship between periodontal disease (PD) and cardiovascular disease (CVD). Mediterr. J. Hematol. Infect. Dis. 2, e2010030 (2010).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"BFnrcardio2016183_CR8","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/bmj.298.6676.779","volume":"298","author":"KJ Mattila","year":"1989","unstructured":"Mattila, K. J. et al. Association between dental health and acute myocardial infarction. BMJ 298, 779\u2013781 (1989).","journal-title":"BMJ"},{"key":"BFnrcardio2016183_CR9","doi-asserted-by":"publisher","first-page":"c2451","DOI":"10.1136\/bmj.c2451","volume":"340","author":"C de Oliveira","year":"2010","unstructured":"de Oliveira, C., Watt, R. & Hamer, M. Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ 340, c2451 (2010).","journal-title":"BMJ"},{"key":"BFnrcardio2016183_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.atherosclerosis.2015.10.097","volume":"243","author":"F Fak","year":"2015","unstructured":"Fak, F., Tremaroli, V., Bergstrom, G. & Backhed, F. Oral microbiota in patients with atherosclerosis. Atherosclerosis 243, 573\u2013578 (2015).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000314686","volume":"2","author":"C Hayashi","year":"2010","unstructured":"Hayashi, C. et al. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J. Innate Immun. 2, 334\u2013343 (2010).","journal-title":"J. Innate Immun."},{"key":"BFnrcardio2016183_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.atherosclerosis.2010.12.009","volume":"215","author":"C Hayashi","year":"2011","unstructured":"Hayashi, C. et al. Porphyromonas gingivalis accelerates inflammatory atherosclerosis in the innominate artery of ApoE deficient mice. Atherosclerosis 215, 52\u201359 (2011).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1574-695X.2010.00674.x","volume":"59","author":"T Zhang","year":"2010","unstructured":"Zhang, T. et al. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol. Med. Microbiol. 59, 143\u2013151 (2010).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"BFnrcardio2016183_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ncomms2266","volume":"3","author":"FH Karlsson","year":"2012","unstructured":"Karlsson, F. H. et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 3, 1245 (2012).","journal-title":"Nat. Commun."},{"key":"BFnrcardio2016183_CR15","doi-asserted-by":"publisher","unstructured":"Emoto, T. et al. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels http:\/\/dx.doi.org\/10.1007\/s00380-016-0841-y (2016).","DOI":"10.1007\/s00380-016-0841-y"},{"key":"BFnrcardio2016183_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.5551\/jat.32672","volume":"23","author":"T Emoto","year":"2016","unstructured":"Emoto, T. et al. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J. Atheroscler. Thromb. 23, 908\u2013921 (2016).","journal-title":"J. Atheroscler. Thromb."},{"key":"BFnrcardio2016183_CR17","first-page":"158","volume":"82","author":"A Shor","year":"1992","unstructured":"Shor, A., Kuo, C. C. & Patton, D. L. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S. Afr. Med. J. 82, 158\u2013161 (1992).","journal-title":"S. Afr. Med. J."},{"key":"BFnrcardio2016183_CR18","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1128\/JCM.34.11.2766-2769.1996","volume":"34","author":"F Blasi","year":"1996","unstructured":"Blasi, F. et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J. Clin. Microbiol. 34, 2766\u20132769 (1996).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrcardio2016183_CR19","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1161\/01.CIR.99.21.2733","volume":"99","author":"M Thomas","year":"1999","unstructured":"Thomas, M. et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 99, 2733\u20132736 (1999).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR20","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1161\/01.STR.31.12.2930","volume":"31","author":"RG Gibbs","year":"2000","unstructured":"Gibbs, R. G. et al. Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis. Stroke 31, 2930\u20132935 (2000).","journal-title":"Stroke"},{"key":"BFnrcardio2016183_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1067\/mlc.2000.108941","volume":"136","author":"M Berger","year":"2000","unstructured":"Berger, M. et al. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes. J. Lab. Clin. Med. 136, 194\u2013200 (2000).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrcardio2016183_CR22","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1161\/hs0901.095633","volume":"32","author":"ZG Nadareishvili","year":"2001","unstructured":"Nadareishvili, Z. G. et al. Increased CD8+ T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque. Stroke 32, 1966\u20131972 (2001).","journal-title":"Stroke"},{"key":"BFnrcardio2016183_CR23","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1161\/hs1201.099631","volume":"32","author":"SC Johnston","year":"2001","unstructured":"Johnston, S. C. et al. C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke 32, 2748\u20132752 (2001).","journal-title":"Stroke"},{"key":"BFnrcardio2016183_CR24","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1111\/odi.12205","volume":"20","author":"CA Calandrini","year":"2014","unstructured":"Calandrini, C. A. et al. Microbial composition of atherosclerotic plaques. Oral Dis. 20, e128\u2013e134 (2014).","journal-title":"Oral Dis."},{"key":"BFnrcardio2016183_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40168-015-0100-y","volume":"3","author":"S Mitra","year":"2015","unstructured":"Mitra, S. et al. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome 3, 38 (2015).","journal-title":"Microbiome"},{"key":"BFnrcardio2016183_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1160\/TH11-06-0392","volume":"106","author":"ME Rosenfeld","year":"2011","unstructured":"Rosenfeld, M. E. & Campbell, L. A. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb. Haemost. 106, 858\u2013867 (2011).","journal-title":"Thromb. Haemost."},{"key":"BFnrcardio2016183_CR27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/01.ATV.20.6.1417","volume":"20","author":"SE Epstein","year":"2000","unstructured":"Epstein, S. E. et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb. Vasc. Biol. 20, 1417\u20131420 (2000).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"BFnrcardio2016183_CR28","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","volume":"351","author":"L Smeeth","year":"2004","unstructured":"Smeeth, L. et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351, 2611\u20132618 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2016183_CR29","doi-asserted-by":"publisher","first-page":"378658","DOI":"10.1155\/2015\/378658","volume":"2015","author":"S Filardo","year":"2015","unstructured":"Filardo, S., Di Pietro, M., Farcomeni, A., Schiavoni, G. & Sessa, R. Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. Mediators Inflamm. 2015, 378658 (2015).","journal-title":"Mediators Inflamm."},{"key":"BFnrcardio2016183_CR30","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.1503\/cmaj.112161","volume":"185","author":"P Hizo-Abes","year":"2013","unstructured":"Hizo-Abes, P. et al. Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis. CMAJ 185, E70\u2013E77 (2013).","journal-title":"CMAJ"},{"key":"BFnrcardio2016183_CR31","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1001\/jama.293.21.2641","volume":"293","author":"R Andraws","year":"2005","unstructured":"Andraws, R., Berger, J. S. & Brown, D. L. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293, 2641\u20132647 (2005).","journal-title":"JAMA"},{"key":"BFnrcardio2016183_CR32","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1161\/01.CIR.0000056032.56396.89","volume":"107","author":"JT Grayston","year":"2003","unstructured":"Grayston, J. T. Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation 107, 1228\u20131230 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR33","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1001\/jama.290.11.1459","volume":"290","author":"CM O'Connor","year":"2003","unstructured":"O'Connor, C. M. et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290, 1459\u20131466 (2003).","journal-title":"JAMA"},{"key":"BFnrcardio2016183_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa043526","volume":"352","author":"JT Grayston","year":"2005","unstructured":"Grayston, J. T. et al. Azithromycin for the secondary prevention of coronary events. N. Engl. J. Med. 352, 1637\u20131645 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2016183_CR35","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMoa043528","volume":"352","author":"CP Cannon","year":"2005","unstructured":"Cannon, C. P. et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N. Engl. J. Med. 352, 1646\u20131654 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2016183_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","volume":"332","author":"CM Jespersen","year":"2006","unstructured":"Jespersen, C. M. et al. Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. BMJ 332, 22\u201327 (2006).","journal-title":"BMJ"},{"key":"BFnrcardio2016183_CR37","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","volume":"488","author":"I Cho","year":"2012","unstructured":"Cho, I. et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621\u2013626 (2012).","journal-title":"Nature"},{"key":"BFnrcardio2016183_CR38","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1111\/j.1747-4949.2010.00420.x","volume":"41","author":"MS Elkind","year":"2010","unstructured":"Elkind, M. S. et al. Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 41, e117\u2013e122 (2010).","journal-title":"Stroke"},{"key":"BFnrcardio2016183_CR39","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/CIRCULATIONAHA.109.849455","volume":"119","author":"SE Epstein","year":"2009","unstructured":"Epstein, S. E., Zhu, J., Najafi, A. H. & Burnett, M. S. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119, 3133\u20133141 (2009).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783\u2013801 (2006).","journal-title":"Cell"},{"key":"BFnrcardio2016183_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499\u2013511 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrcardio2016183_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-5793(02)02692-3","volume":"519","author":"MA Ostos","year":"2002","unstructured":"Ostos, M. A., Recalde, D., Zakin, M. M. & Scott-Algara, D. Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation. FEBS Lett. 519, 23\u201329 (2002).","journal-title":"FEBS Lett."},{"key":"BFnrcardio2016183_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.11.015","volume":"244","author":"DM Rocha","year":"2016","unstructured":"Rocha, D. M., Caldas, A. P., Oliveira, L. L., Bressan, J. & Hermsdorff, H. H. Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244, 211\u2013215 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","volume":"22","author":"R Caesar","year":"2015","unstructured":"Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D. & Backhed, F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. 22, 658\u2013668 (2015).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm1008","volume":"10","author":"H Bjorkbacka","year":"2004","unstructured":"Bjorkbacka, H. et al. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10, 416\u2013421 (2004).","journal-title":"Nat. Med."},{"key":"BFnrcardio2016183_CR46","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"KS Michelsen","year":"2004","unstructured":"Michelsen, K. S. et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl Acad. Sci. USA 101, 10679\u201310684 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016183_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/circ.105.10.1158","volume":"105","author":"K Edfeldt","year":"2002","unstructured":"Edfeldt, K., Swedenborg, J., Hansson, G. K. & Yan, Z. Q. Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105, 1158\u20131161 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR48","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1161\/hc5001.100631","volume":"104","author":"XH Xu","year":"2001","unstructured":"Xu, X. H. et al. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104, 3103\u20133108 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/76048","volume":"25","author":"NC Arbour","year":"2000","unstructured":"Arbour, N. C. et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187\u2013191 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrcardio2016183_CR50","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/j.thromres.2012.07.008","volume":"130","author":"K Zhang","year":"2012","unstructured":"Zhang, K. et al. Lack of association between TLR4 Asp299Gly polymorphism and atherosclerosis: evidence from meta-analysis. Thromb. Res. 130, e203\u2013208 (2012).","journal-title":"Thromb. Res."},{"key":"BFnrcardio2016183_CR51","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F Backhed","year":"2004","unstructured":"Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718\u201315723 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016183_CR52","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761\u20131772 (2007).","journal-title":"Diabetes"},{"key":"BFnrcardio2016183_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99\u2013103 (2013).","journal-title":"Nature"},{"key":"BFnrcardio2016183_CR54","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1161\/hc4601.099487","volume":"104","author":"S Yusuf","year":"2001","unstructured":"Yusuf, S., Reddy, S., Ounpuu, S. & Anand, S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104, 2746\u20132753 (2001).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR55","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","volume":"117","author":"J Fu","year":"2015","unstructured":"Fu, J. et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ. Res. 117, 817\u2013824 (2015).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016183_CR56","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1194\/jlr.M002774","volume":"51","author":"VR Velagapudi","year":"2010","unstructured":"Velagapudi, V. R. et al. The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51, 1101\u20131112 (2010).","journal-title":"J. Lipid Res."},{"key":"BFnrcardio2016183_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. & Staels, B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89, 147\u2013191 (2009).","journal-title":"Physiol. Rev."},{"key":"BFnrcardio2016183_CR58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"Wahlstrom, A., Sayin, S. I., Marschall, H. U. & Backhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR60","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1038\/ncomms3384","volume":"4","author":"F Li","year":"2013","unstructured":"Li, F. et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat. Commun. 4, 2384 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrcardio2016183_CR61","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang, C. et al. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J. Clin. Invest. 125, 386\u2013402 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio2016183_CR62","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1038\/ncomms10166","volume":"6","author":"C Jiang","year":"2015","unstructured":"Jiang, C. et al. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. Nat. Commun. 6, 10166 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrcardio2016183_CR63","doi-asserted-by":"publisher","unstructured":"Parseus, A. et al. Microbiota-induced obesity requires farnesoid X receptor. Gut http:\/\/dx.doi.org\/10.1136\/gutjnl-2015-310283 (2016).","DOI":"10.1136\/gutjnl-2015-310283"},{"key":"BFnrcardio2016183_CR64","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1074\/jbc.M209525200","volume":"278","author":"G Lambert","year":"2003","unstructured":"Lambert, G. et al. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J. Biol. Chem. 278, 2563\u20132570 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio2016183_CR65","doi-asserted-by":"publisher","first-page":"e108270","DOI":"10.1371\/journal.pone.0108270","volume":"9","author":"S Miyazaki-Anzai","year":"2014","unstructured":"Miyazaki-Anzai, S., Masuda, M., Levi, M., Keenan, A. L. & Miyazaki, M. Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis. PLoS ONE 9, e108270 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2016183_CR66","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1194\/jlr.M800619-JLR200","volume":"50","author":"HB Hartman","year":"2009","unstructured":"Hartman, H. B. et al. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR\u2212\/\u2212 and apoE\u2212\/\u2212 mice. J. Lipid Res. 50, 1090\u20131100 (2009).","journal-title":"J. Lipid Res."},{"key":"BFnrcardio2016183_CR67","doi-asserted-by":"publisher","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","volume":"296","author":"A Mencarelli","year":"2009","unstructured":"Mencarelli, A., Renga, B., Distrutti, E. & Fiorucci, S. Antiatherosclerotic effect of farnesoid X receptor. Am. J. Physiol. Heart Circ. Physiol. 296, H272\u2013H281 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio2016183_CR68","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1194\/jlr.M500390-JLR200","volume":"46","author":"EA Hanniman","year":"2005","unstructured":"Hanniman, E. A., Lambert, G., McCarthy, T. C. & Sinal, C. J. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice. J. Lipid Res. 46, 2595\u20132604 (2005).","journal-title":"J. Lipid Res."},{"key":"BFnrcardio2016183_CR69","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.bbalip.2006.09.018","volume":"1761","author":"GL Guo","year":"2006","unstructured":"Guo, G. L. et al. Effects of FXR in foam-cell formation and atherosclerosis development. Biochim. Biophys. Acta 1761, 1401\u20131409 (2006).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrcardio2016183_CR70","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1161\/01.ATV.0000235697.35431.05","volume":"26","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y. et al. FXR deficiency causes reduced atherosclerosis in Ldlr\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 26, 2316\u20132321 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio2016183_CR71","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1073\/pnas.0400046101","volume":"101","author":"D Bishop-Bailey","year":"2004","unstructured":"Bishop-Bailey, D., Walsh, D. T. & Warner, T. D. Expression and activation of the farnesoid X receptor in the vasculature. Proc. Natl Acad. Sci. USA 101, 3668\u20133673 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016183_CR72","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/cvr\/cvm068","volume":"77","author":"Q Zhang","year":"2008","unstructured":"Zhang, Q. et al. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc. Res. 77, 560\u2013569 (2008).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio2016183_CR73","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.RES.0000200400.55539.85","volume":"98","author":"F He","year":"2006","unstructured":"He, F. et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ. Res. 98, 192\u2013199 (2006).","journal-title":"Circ. Res."},{"key":"BFnrcardio2016183_CR74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature18846","volume":"535","author":"J Sonnenburg","year":"2016","unstructured":"Sonnenburg, J. & B\u00e4ckhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56\u201364 (2016).","journal-title":"Nature"},{"key":"BFnrcardio2016183_CR75","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2014.12.036","volume":"148","author":"H Tilg","year":"2015","unstructured":"Tilg, H. & Moschen, A. R. Food, immunity, and the microbiome. Gastroenterology 148, 1107\u20131119 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrcardio2016183_CR76","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","volume":"142","author":"S Pendyala","year":"2012","unstructured":"Pendyala, S., Walker, J. M. & Holt, P. R. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology 142, 1100\u20131101.e2 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrcardio2016183_CR77","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/ajcn\/86.5.1286","volume":"86","author":"C Erridge","year":"2007","unstructured":"Erridge, C., Attina, T., Spickett, C. M. & Webb, D. J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86, 1286\u20131292 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrcardio2016183_CR78","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1021\/acs.jproteome.5b00032","volume":"14","author":"D Li","year":"2015","unstructured":"Li, D. et al. Metabonomic changes associated with atherosclerosis progression for LDLR\u2212\/\u2212 mice. J. Proteome Res. 14, 2237\u20132254 (2015).","journal-title":"J. Proteome Res."},{"key":"BFnrcardio2016183_CR79","doi-asserted-by":"publisher","first-page":"e108577","DOI":"10.1371\/journal.pone.0108577","volume":"9","author":"SS Ghosh","year":"2014","unstructured":"Ghosh, S. S., Bie, J., Wang, J. & Ghosh, S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR\u2212\/\u2212 mice\u2014role of intestinal permeability and macrophage activation. PLoS ONE 9, e108577 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2016183_CR80","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5551\/jat.3285","volume":"17","author":"R Stepankova","year":"2010","unstructured":"Stepankova, R. et al. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet. J. Atheroscler. Thromb. 17, 796\u2013804 (2010).","journal-title":"J. Atheroscler. Thromb."},{"key":"BFnrcardio2016183_CR81","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1084\/jem.191.8.1437","volume":"191","author":"SD Wright","year":"2000","unstructured":"Wright, S. D. et al. Infectious agents are not necessary for murine atherogenesis. J. Exp. Med. 191, 1437\u20131442 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrcardio2016183_CR82","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00335-014-9540-0","volume":"25","author":"A O'Connor","year":"2014","unstructured":"O'Connor, A., Quizon, P. M., Albright, J. E., Lin, F. T. & Bennett, B. J. Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mamm. Genome 25, 583\u2013599 (2014).","journal-title":"Mamm. Genome"},{"key":"BFnrcardio2016183_CR83","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1101\/gr.194118.115","volume":"25","author":"E Org","year":"2015","unstructured":"Org, E. et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 25, 1558\u20131569 (2015).","journal-title":"Genome Res."},{"key":"BFnrcardio2016183_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"BFnrcardio2016183_CR85","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"BFnrcardio2016183_CR86","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cmet.2014.10.006","volume":"20","author":"RA Koeth","year":"2014","unstructured":"Koeth, R. A. et al. \u03b3-butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of l-carnitine to TMAO. Cell Metab. 20, 799\u2013812 (2014).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR87","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2016.01.033","volume":"247","author":"K Skagen","year":"2016","unstructured":"Skagen, K. et al. The carnitine\u2013butyrobetaine\u2013trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis 247, 64\u201369 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR88","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang, W. H. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575\u20131584 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio2016183_CR89","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904\u2013910 (2014).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio2016183_CR90","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cjca.2015.06.016","volume":"31","author":"A Mente","year":"2015","unstructured":"Mente, A. et al. The relationship between trimethylamine-N-oxide and prevalent cardiovascular disease in a multiethnic population living in Canada. Can. J. Cardiol. 31, 1189\u20131194 (2015).","journal-title":"Can. J. Cardiol."},{"key":"BFnrcardio2016183_CR91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cardfail.2014.11.006","volume":"21","author":"WH Tang","year":"2015","unstructured":"Tang, W. H. et al. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21, 91\u201396 (2015).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio2016183_CR92","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang, W. H. et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908\u20131914 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio2016183_CR93","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"M Troseid","year":"2015","unstructured":"Troseid, M. et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 277, 717\u2013726 (2015).","journal-title":"J. Intern. Med."},{"key":"BFnrcardio2016183_CR94","doi-asserted-by":"publisher","first-page":"e1005711","DOI":"10.1371\/journal.pgen.1005711","volume":"11","author":"BJ Bennett","year":"2015","unstructured":"Bennett, B. J. et al. Genetic architecture of atherosclerosis in mice: a systems genetics analysis of common inbred strains. PLoS Genet. 11, e1005711 (2015).","journal-title":"PLoS Genet."},{"key":"BFnrcardio2016183_CR95","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","volume":"290","author":"JC Gregory","year":"2015","unstructured":"Gregory, J. C. et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J. Biol. Chem. 290, 5647\u20135660 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio2016183_CR96","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","volume":"6","author":"KA Romano","year":"2015","unstructured":"Romano, K. A., Vivas, E. I., Amador-Noguez, D. & Rey, F. E. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio 6, e02481 (2015).","journal-title":"mBio"},{"key":"BFnrcardio2016183_CR97","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2015.10.108","volume":"244","author":"HL Collins","year":"2016","unstructured":"Collins, H. L. et al. L-carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE\u2212\/\u2212 transgenic mice expressing CETP. Atherosclerosis 244, 29\u201337 (2016).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR98","doi-asserted-by":"publisher","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin, M. M. et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. J. Am. Heart Assoc. 5, e002767 (2016).","journal-title":"J. Am. Heart Assoc."},{"key":"BFnrcardio2016183_CR99","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165, 111\u2013124 (2016).","journal-title":"Cell"},{"key":"BFnrcardio2016183_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett, B. J. et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17, 49\u201360 (2013).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR101","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1194\/jlr.M051680","volume":"56","author":"DM Shih","year":"2015","unstructured":"Shih, D. M. et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J. Lipid Res. 56, 22\u201337 (2015).","journal-title":"J. Lipid Res."},{"key":"BFnrcardio2016183_CR102","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"M Warrier","year":"2015","unstructured":"Warrier, M. et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep. 10, 326\u2013338 (2015).","journal-title":"Cell Rep."},{"key":"BFnrcardio2016183_CR103","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao, J. et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun. 6, 6498 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrcardio2016183_CR104","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2174\/1389200033489505","volume":"4","author":"JR Cashman","year":"2003","unstructured":"Cashman, J. R. et al. Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria. Curr. Drug Metab. 4, 151\u2013170 (2003).","journal-title":"Curr. Drug Metab."},{"key":"BFnrcardio2016183_CR105","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"ZN Wang","year":"2015","unstructured":"Wang, Z. N. et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163, 1585\u20131595 (2015).","journal-title":"Cell"},{"key":"BFnrcardio2016183_CR106","doi-asserted-by":"publisher","first-page":"e02210-15","DOI":"10.1128\/mBio.02210-15","volume":"7","author":"ML Chen","year":"2016","unstructured":"Chen, M. L. et al. Resveratrol attenuates trimethylamine-N-Oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio 7, e02210-15 (2016).","journal-title":"mBio"},{"key":"BFnrcardio2016183_CR107","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmet.2015.07.009","volume":"22","author":"V Tremaroli","year":"2015","unstructured":"Tremaroli, V. et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 22, 228\u2013238 (2015).","journal-title":"Cell Metab."},{"key":"BFnrcardio2016183_CR108","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/nu5041417","volume":"5","author":"J Slavin","year":"2013","unstructured":"Slavin, J. Fiber and prebiotics: mechanisms and health benefits. Nutrients 5, 1417\u20131435 (2013).","journal-title":"Nutrients"},{"key":"BFnrcardio2016183_CR109","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/ajcn\/83.1.124","volume":"83","author":"NR Sahyoun","year":"2006","unstructured":"Sahyoun, N. R., Jacques, P. F., Zhang, X. L., Juan, W. & McKeown, N. M. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am. J. Clin. Nutr. 83, 124\u2013131 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrcardio2016183_CR110","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1017\/BJN20061913","volume":"96","author":"MH Rault-Nania","year":"2006","unstructured":"Rault-Nania, M. H. et al. Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br. J. Nutr. 96, 840\u2013844 (2006).","journal-title":"Br. J. Nutr."},{"key":"BFnrcardio2016183_CR111","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2009.06.019","volume":"208","author":"C Karlsson","year":"2010","unstructured":"Karlsson, C. et al. Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. Atherosclerosis 208, 228\u2013233 (2010).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio2016183_CR112","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/ajcn\/76.6.1249","volume":"76","author":"M Naruszewicz","year":"2002","unstructured":"Naruszewicz, M., Johansson, M. L., Zapolska-Downar, D. & Bukowska, H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76, 1249\u20131255 (2002).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrcardio2016183_CR113","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3168\/jds.S0022-0302(00)74895-8","volume":"83","author":"MP Taranto","year":"2000","unstructured":"Taranto, M. P., Medici, M., Perdigon, G., Ruiz Holgado, A. P. & Valdez, G. F. Effect of Lactobacillus reuteri on the prevention of hypercholesterolemia in mice. J. Dairy Sci. 83, 401\u2013403 (2000).","journal-title":"J. Dairy Sci."},{"key":"BFnrcardio2016183_CR114","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1017\/S0022029909990173","volume":"76","author":"S Andrade","year":"2009","unstructured":"Andrade, S. & Borges, N. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J. Dairy Res. 76, 469\u2013474 (2009).","journal-title":"J. Dairy Res."},{"key":"BFnrcardio2016183_CR115","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3945\/jn.114.191627","volume":"144","author":"LE London","year":"2014","unstructured":"London, L. E. et al. Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. J. Nutr. 144, 1956\u20131962 (2014).","journal-title":"J. Nutr."},{"key":"BFnrcardio2016183_CR116","doi-asserted-by":"publisher","first-page":"e46837","DOI":"10.1371\/journal.pone.0046837","volume":"7","author":"F Fak","year":"2012","unstructured":"Fak, F. & Backhed, F. Lactobacillus reuteri prevents diet-induced obesity, but not atherosclerosis, in a strain dependent fashion in Apoe\u2212\/\u2212 mice. PLoS ONE 7, e46837 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrcardio2016183_CR117","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1590\/S0100-879X2006000500010","volume":"39","author":"LR Portugal","year":"2006","unstructured":"Portugal, L. R. et al. Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice. Braz. J. Med. Biol. Res. 39, 629\u2013635 (2006).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFnrcardio2016183_CR118","doi-asserted-by":"publisher","first-page":"7767","DOI":"10.1128\/AEM.01477-07","volume":"73","author":"MC Collado","year":"2007","unstructured":"Collado, M. C., Derrien, M., Isolauri, E., de Vos, W. M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767\u20137770 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrcardio2016183_CR119","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1128\/AEM.01226-07","volume":"74","author":"M Derrien","year":"2008","unstructured":"Derrien, M., Collado, M. C., Ben-Amor, K., Salminen, S. & de Vos, W. M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74, 1646\u20131648 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"BFnrcardio2016183_CR120","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066\u20139071 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio2016183_CR121","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/CIRCULATIONAHA.115.019645","volume":"133","author":"J Li","year":"2016","unstructured":"Li, J., Lin, S., Vanhoutte, P. M., Woo, C. W. & Xu, A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe\u2212\/\u2212 Mice. Circulation 133, 2434\u20132446 (2016).","journal-title":"Circulation"},{"key":"BFnrcardio2016183_CR122","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1126\/science.aad6753","volume":"351","author":"AL Byrd","year":"2016","unstructured":"Byrd, A. L. & Segre, J. A. Infectious disease. Adapting Koch's postulates. Science 351, 224\u2013226 (2016).","journal-title":"Science"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2016.183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:58:20Z","timestamp":1684468700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2016.183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFnrcardio2016183"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2016.183","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]},"assertion":[{"value":"1 December 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.B. is founder and shareholder of Metabogen AB. A.L.J. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}